Sidebar
Outpatient Visits for COVID-19 and Associated Antibiotic Prescriptions Among Medicare Beneficiaries Aged 65 Years or Older, by Setting, US, April ...
The street price of prescription drugs as well as illicit drugs is captured through a publicly-accessible website www.StreetRx.com. The site ...
STD's resurged in the United States by the end of 2020 following a decline in reported cases of chlamydia, gonorrhea ...
This metric shows whether SARS-CoV-2 levels at a site are currently higher or lower than past historical levels at the ...
The vast majority (89%) of those who attempted to get an in-person COVID-19 test in the past month say they ...
An app shows trends in COVID-19 cases, deaths, wastewater surveillance, and other key metrics for the state of North Carolina. ...
CDC’s efforts with forecasting began in 2013 with the “Predict the Influenza Season Challenge”, a competition that encouraged outside academic ...
Growth in the total personal healthcare cost is equal to the sum of economy wide and relative inflation and is ...
We trend the frequency of specific search terms from 2021 to the present used by the American public when looking ...
The data categorizes expenditures as national health expenditures, health consumption costs, personal health costs, administrative costs, and public health activities ...
France, Israel, Denmark, and Ireland have the highest cases per capita of Omicron in the world. This shows what happens ...
Weighted averages subject to change over time as modeled projections reflect later data. Source: Centers for Disease Control and Prevention ...
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy